BSPM Stock Overview
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biostar Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0095 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -98.95% |
| 1 Year Change | n/a |
| 3 Year Change | -99.94% |
| 5 Year Change | -99.93% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BSPM | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.2% |
| 1Y | n/a | 9.7% | 19.3% |
Return vs Industry: Insufficient data to determine how BSPM performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BSPM performed against the US Market.
Price Volatility
| BSPM volatility | |
|---|---|
| BSPM Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BSPM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BSPM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Ronghua Wang | biostarpharmaceuticals.com |
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company’s OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract.
Biostar Pharmaceuticals, Inc. Fundamentals Summary
| BSPM fundamental statistics | |
|---|---|
| Market cap | US$263.00 |
| Earnings (TTM) | US$934.35k |
| Revenue (TTM) | US$317.79k |
0.0x
P/E Ratio0.0x
P/S RatioIs BSPM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSPM income statement (TTM) | |
|---|---|
| Revenue | US$317.79k |
| Cost of Revenue | US$354.54k |
| Gross Profit | -US$36.75k |
| Other Expenses | -US$971.10k |
| Earnings | US$934.35k |
Last Reported Earnings
Sep 30, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BSPM perform over the long term?
See historical performance and comparison